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Abstract 
The interaction of the Maackia amurensis hemagglutinin (MAH) with various glycopeptides and oligosaccharides was investigated by means of 
immobilized lectin affinity chromatography. An amino terminal octapeptide obtained from human glycophorin A having three 
Neu5Aca2+3Gal/I1+3(Neu5Aca2+6)GalNAc tetrasaccharide chains, designated as CB-II, was found to have an extremely strong affinity for 
MAH. Therefore, it is strongly suggested that hemagglutination by MAH was caused by its interaction with Ser/Thr-linked carbohydrate chains of 
human glycophorin A on erythrocyte membranes. 
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1. Introduction 
Two isolectins were previously purified from Maackia 
amurensis seeds in this laboratory [I]. They were desig- 
nated as Maackia amurensis hemagglutinin (MAH) and 
Maackia amurensis leukoagglutinin (MAL) because of 
their agglutination activity towards different blood cells 
[I]. Between 1974 and 1976 we described the carbohy- 
drate binding specificity of these isolectins and the simi- 
larity of their carbohydrate binding specificity with other 
lectins as revealed by hemagglutination inhibition tests 
and competitive binding assays to human erythrocytes 
[2,3]. The results strongly suggested that MAH preferen- 
tially binds Ser/Thr-linked carbohydrate chains whereas 
MAL binds Asn-linked carbohydrate chains [2,3]. In 
1988 and 1991, additional studies on the carbohydrate 
binding specificity of MAL were performed in other lab- 
oratories [4,5]. As a result of these studies, it became 
clear that MAL strongly binds carbohydrate chains con- 
taining sialic acid, particularly the NeuSAca2+ 
3Gal/Il+4GlcNAc sequence. However, the detailed car- 
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bohydrate binding specificity of another isolectin, MAH, 
was not extensively studied. In our early work, porcine 
submaxillary gland mucin (PSM) was found to be a 
strong haptenic inhibitor of MAH-induced hemaggluti- 
nation and the reactivity was attributed to its sialic acid- 
containing Ser/Thr-linked carbohydrate chains [ 11. 
Therefore, contribution of sialyl residues in the ligand 
activity for MAH was also likely. In the present study, 
we have investigated the carbohydrate binding specificity 
of MAH by means of immobilized affinity chromatogra- 
phy with various glycopeptides and oligosaccharides 
having defined carbohydrate structures. 
2. Materials and methods 
2.1. Materials 
The seeds of Maackia amurensis were obtained from F.W. Schuma- 
cher. Sandwich. MA. USA. Senharose 4B and Senhadex G-25 were 
purchased from Pharmacia, Uppsala, Sweden. Fetuin from bovine 
serum and a2+3 specific sialidase from Salmonella typhimurium were 
obtained from Sigma, St. Louis, MO, USA. Pronase from Streptomyces 
griseus was purchased from Kaken Kagaku, Tokyo, Japan. [‘%jAcetic 
anhydride was obtained from New England Nuclear, Boston, MA, 
USA. 
2.2. Preparation of specific affinity absorbent, fetuin-glycopeptide- 
Sepharose 4B 
Kawaguchi et al. [1] partially purified MAH by affinity chromatogra- 
nhv on a column of Senharose 4B containing covalently bound 
glycopeptides derived from porcine thyroglobulin and observed that 
MAH preferentially binds to a structure in the sialic acid-containing 
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carbohydrate chains of the PSM molecule. Because bovine fetuin was 
known to contain Ser/Thr-linked carbohydrate chains having either the 
structure NeuSAca2+3Ga~1-+3GalNAc or NeuSAca2+3Gal@+ 
3(NeuSAca2+6)GalNAc and Asn-linked carbohydrate chains having 
both ~2-16 and a2+3 specific sialic acid linkages [6,7], we used a 
mixture of fetuin glycopeptides as the affinity absorbent. Bovine fetuin 
was exhaustively digested with pronase according to the procedure 
described by Fukuda and Egami [8]. The obtained glycopeptides were 
purified by gel filtration on a column of Sephadex G-25. A mixture of 
glycopeptides prepared from bovine fetuin was coupled to cyanogen 
bromide-activated Sepharose 4B according to a previously described 
method (Fetuin-GP-Sepharose) [9]. 
2.3. Purification of Maackia amurensis hemagglutinin (MAH) 
MAH was isolated and purified from Maackia amurensis seeds by the 
method of Kawaguchi et al. [l] with modifications. The seeds were 
finely ground in an electric seed mill and extracted overnight with 0.9% 
NaCl solution. Ammonium sulfate was added to the extract, and the 
30%-80% ammonium sulfate precipitate was collected and dialyzed 
against water. The dialyzed material was applied to an affinity column 
of Fetuin-GP-Sepharose, washed with 50 mM Tris-HCl, pH 7.5, and 
eluted with 50 mM glycine-HCl, pH 3.0. The eluted protein was 
dialyzed against 50 mM phosphate buffer, pH 5.0, and applied to a 
SP-Toyopearl ion exchange column. After a large peak was eluted with 
the same buffer, the absorbed protein was eluted with the same buffer 
containing 1 N NaCl. The eluate containing MAH was collected, 
pooled, and lyophilized. The affinity-isolated MAH was further puri- 
fied by reversed-phase high-performance liquid chromatography on a 
column of C,, using a linear gradient (O-100%) of 2-propanol/ace.toni- 
trile (7:3) in distilled water containing 0.1% TFA in 60 min at a flow 
rate of 1 ml/min. The purified MAH was free from contamination of 
MAH as judged by polyacrylamide gel electrophoresis n the absence 
or in the presence of b-mercaptoethanol and by the determination of 
the N-terminal amino acid sequence. 
2.4. Preparation of MAH-Sepharose 4B column 
The purified MAH was coupled to cyanogen bromide-activated 
Sepharose 4B [lo] at a concentration of 3.6 mg/ml gels. Radiolabeled 
oligosaccharide or glycopeptide samples (2,000 cpm in 100 ml) were 
loaded onto a column of MAH-Sepharose 4B (0.6 x 4.0 cm) equili- 
brated with 10 mM Tris-HCl, pH 7.5, containing 0.15 M NaCl. After 
the column was eluted with the same buffer, bound material was eluted 
with 50 mM glycine-HCl, pH 5.0, or 0.1 N NaOH. Fractions (0.2 ml) 
were collected at a flow rate of 0.6 ml/h at room temperature. The 
radioactivity of each fraction was measured on a liquid scintillation 
counter. 
2.5. Preparation of labeled glycopeptides and oligosaccharides 
Asn-linked glycopeptides were prepared by repeated pronase diges- 
tion of the corresponding lycoproteins [l 11. In some cases, oligosac- 
charides were released from glycopeptides by hydrazinolysis as 
previously described [l 11. Triantennary disialo complex-type Asn- 
linked oligosaccharides (PTG UB tri, a) were prepared from porcine 
thyroglobulin by the method described in a previous paper [12]. Bian- 
tennary disialo complex-type Asn-linked glycopeptides were prepared 
from human serum transferrin (hTf bi, b) as previously described [l 11. 
Desialylated biantennary complex-type Asn-linked glycopeptides (hTf 
bi (-SA), c) were prepared after incubation of the sialylated glycopep- 
tides (hTf bi, b) with a2+3 specific Salmonella typhimurium sialidase 
(0.2-0.5 units) in 0.1 M sodium acetate buffer, pH 5.5, for 20 h. Bian- 
tennary disialo complex-type Asn-linked oligosaccharides having a bi- 
secting N-acetylglucosamine r sidue and a fucose residue linked to the 
innermost iV-acetylglucosamine residue (hGph bi, d) were isolated from 
a tryptic fragment, Tl , of human glycophorin A [ 131. Poly-N-acetyllac- 
tosamine type carbohydrate chains were obtained from human erythro- 
cyte membrane Band 3 glycoprotein (N-l, e) [14]. The N-terminal 
octapeptides from human erythrocyte glycophorin A (CB-II) were pre- 
pared from the tryptic fragment, Tl, according to the method of 
Prohaska et al. by cyanogen bromide cleavage [15]. The structures of 
all oligosaccharides and glycopeptides used in this study were con- 
firmed by compositional analyses, methylation analyses, and sequential 
glycosidase digestions [ll-141. Fig. 1 shows the structures of these 
Asn-linked glycopeptides and oligosaccharides. The glycopeptides 
(5- 50 pg) were acetylated with [14C]acetic anhydride (2 mCi/mmol) in 
0.1 ml of 4.5 M sodium acetate at room temperature for 5 min. Labeled 
glycopeptides were isolated by gel filtration on Sephadex G-25. The 
oligosaccharides were labeled by reduction with NaB’H, according to 
the method previously described [16]. Specific activity of ‘YYabeled 
glycopeptides and ‘H-labeled oligosaccharides were approximately 
7.5 x 10”’ and 8.9 x 10” dpm/mmol, respectively. 
2.6. Mod$cation of glycopeptides CB-II 
The sialic acid residues of intact [‘4C]CB-II was removed by mild acid 
hydrolysis in 50 mM HCl at 80°C for 1 h. Asialo, agalacto [‘4C]CB-II 
was obtained after Smith periodate degradation of asialo [‘4C]CB-II 
[17]. The a2-+3 linked sialic acid residues of [‘4C]CB-II were removed 
by a2+3 specific sialidase from Salmonella typhimurium (Sigma). The 
removal of the sialic acid residues was confirmed by the eluting position 
of the anion-exchange chromatography on a Mono Q column (Pharma- 
cia, Sweden). Fig. 2 summarizes the structures of the derivatives of 
CB-II used in this study. 
3. Results 
3.1. AfJinity chromatography of glycopeptides with 
SerlThr-linked carbohydrate chains on immobilized 
MAH 
In order to elucidate the carbohydrate-binding speci- 
ficity of MAH, affinity chromatography of various 
glycopeptides and oligosaccharides on the immobilized 
MAH column was performed. Fig. 3 shows the elution 
profiles of glycopeptide CB-II and the digestion products 
from CB-II. Intact [‘4C]CB-II, obtained by cyanogen 
bromide cleavage of human glycophorin A, constitutes 
the N-terminal portion of this glycoprotein and contains 
three Ser/Thr-linked tetrasaccharides. Intact [‘4C]CB-II 
showed a very strong affinity for the MAH column and 
could not be eluted with lactose (which was known to 
inhibit hemagglutination by MAH at high concentra- 
tions) or Gly-HCl buffer, pH 3.0. Bound glycopeptides 
were eluted using 0.1 N NaOH as shown in this figure. 
The removal of a single sialic acid residue attached to 
galactosyl residues in each tetrasaccharide of intact 
[14C]CB-II by digestion with a2+3 specific sialidase 
markedly decreased the affinity of the obtained 
glycopeptides, ([‘4C]CB-II (-2,3 SA)), for the MAH- 
Sepharose column. The affinity of [14C]CB-II (-2,3 SA) 
is much weaker than that of intact [14C]CB-II judging 
from the slight retardation from the MAH-Sepharose 
column instead of the strong binding of intact [14C]CB- 
II. Desialylated [14C]CB-II (CB-II (-SA)) and asialo, 
agalacto-[‘4C]CB-II (CB-II (-SA, -Gal)) did not show 
retardation from the column. 
3.2. Affinity chromatography of glycopeptides with Asn- 
linked carbohydrate chains on immobilized MAH 
Elution profiles of Asn-linked carbohydrate chains on 
the immobilized MAH column were also compared. Tri- 
antennary disialo complex-type Asn-linked oligosac- 
charides from porcine thyroglobulin (PTG UB tri, a) 
[ 111, biantennary disialo complex-type Asn-linked 
glycopeptides (hTf bi, b) and desialylated biantennary 
complex-type Asn-linked glycopeptides (hTf bi (-SA), c) 
from human serum transferrin [12], biantennary disialo 
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Fig. 1. Structures of various glycopeptides and oligosaccharides containing Asn-linked carbohydrate chains used in this study. Details are described 
in section 2. 
complex-type Asn-linked oligosaccharides having a bi- 
secting N-acetylglucosamine r sidue and a fucose residue 
linked to the innermost N-acetylglucosamine residue 
(hGph bi, d) [ 131, and poly-N-acetyllactosamine type car- 
bohydrate chains obtained from human erythrocyte 
membrane Band 3 glycoprotein (N-I, e) [14] were used. 
Retardation was not observed with any of these 14C- 
labeled glycopeptides or 3H-labeled oligosaccharides. It
should be noted that the oligosaccharides (hGph, bi, d) 
did not bind MAH despite the fact that it was derived 
from human glycophorin A. The carbohydrate chains 
from another major erythrocyte membrane glycoprotein, 
Band 3 glycoprotein (N-I e), did not have affinity for this 
column. 
4. Discussion 
There are several lectins of plant or animal origins that 
recognize carbohydrate chains containing sialic acid 
[ 12,17-261. Among a variety of legume lectins, however, 
lectins from Maackia amurensis seeds seem to be the only 
exceptions that bind sialylated carbohydrate chains. The 
carbohydrate structure required for an isolectin from 
these seeds, MAH, is not known. In the present report, 
we propose that MAH binds to sialylated carbohydrate 
chains with different structural features from the carbo- 
hydrate chains recognized by MAL. 
It is known that MAH binds Ser/Thr-linked oligosac- 
charides from the porcine submaxillary gland glycopro- 
tein [ 11. In competitive binding assays to human erythro- 
cytes, this lectin was found to compete with Bauhinia 
purpurea agglutinin, that binds Ser/Thr-linked carbohy- 
drate chains on the surface of human erythrocytes [2,13]. 
Thus, it was suggested that glycophorin A (PAS-l 
glycoprotein) [27] consisted of the major binding site for 
MAH on erythrocyte surfaces. MAH did not effectively 
compete with MAL or with Ricinus communis agglutinin- 
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chains at the amino terminal domain of human glyco- affinity for the MAH-Sepharose column, suggesting that 
phorin A possessed a high afhnity for MAH. Sialic a sialic acid residue linked to position 6 of the N-ace- 
acid linked to position 3 of the subterminal galactose tylgalactosamine in the tetrasaccharide unit did not con- 
in the tetrasaccharide unit Neu5Ac&2+3Gal,81+ tribute to the strong interaction between MAH and CB- 
3(NeuSAca2+6)GalNAc was essential to the binding. II. Alternatively, two sialic acid residues in a single Ser/ 
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Fig. 3. Elution profiles of glycopeptide CB-II and its derivatives on a column of MAH-Sepharose. Open circle, CB-II with intact carbohydrate chains. 
Open square, CB-II after removal of 2+34inked sialyl residues. Closed circle, CB-II after removal of all sialyl residues. Closed square, CB-II after 
removal of all sialyl and galactosyl residues. Arrow indicates the eluting position where the elution buffer was switched to 0.1 N NaOH. Vo indicates 
the position of the void volume fraction. 
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essential to the affinity. It remains to be elucidated 
whether a single carbohydrate chain alone had a strong 
affinity for MAH. It was not clear from the results 
whether a Ser/Thr residue was necessary. All Asn-linked 
carbohydrate chains used in this study did not show an 
affinity for MAH. A variety of Asn-linked carbohydrate 
chains other than those used in this study may be neces- 
sary before concluding that MAH does not interact with 
any Asn-linked carbohydrate chains. Another isolectin 
from Maackia amurensis seeds, MAL, is known to have 
a strong affinity for Neu5Accx2+3Gal/?l+4GlcNAc se- 
quences [4,5], and is not supposed to bind to 
Neu5Aca2+3Gal/?l+3(Neu5Aca2+6)GalNAc tetra- 
saccharides. Intact [14C]CB-II applied to a MAL-Sepha- 
rose 4B column under the same conditions described in 
this paper showed a slight retardation from the MAL- 
Sepharose column (data not shown). 
As far as the interaction with human erythrocyte mem- 
brane surfaces is concerned, MAH is likely to interact 
only with Ser/Thr-linked carbohydrate chains of glyco- 
phorin A, because Asn-linked carbohydrate chains of 
glycophorin A or those of Band 3 glycoproteins did not 
have affinity for MAH. It would be very useful if MAH 
recognizes the heavily sialylated mucin-like domains of 
cell surface glycoproteins regardless of the core polypep- 
tides structures. 
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